• Home
  • News
  • Advertise With Us
  • Company A-Z
  • Analysis
  • About Us
  • Products & Services
  • Comment
  • About Pharma Technology Focus Magazine
  • Company Releases
  • Projects
  • About Us Online
  • White Papers
  • Events
  • Contact Us
  • Videos

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Advertise with us
  • Log In
    Log InMarket & Customer Insight
  • Register
  • Advertise with us
  • Home
  • News
  • Advertise With Us
  • Company A-Z
  • Analysis
  • About Us
  • Products & Services
  • Comment
  • About Pharma Technology Focus Magazine
  • Company Releases
  • Projects
  • About Us Online
  • White Papers
  • Events
  • Contact Us
  • Videos
  • APIs

    APIs

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    Vaccine development: the need for speed

    Comment

    Lack of CMO availability threatens cell and gene therapy development

    Comment

    Novaliq’s NovaTears+Omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye

  • Approvals

    Approvals

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    News

    FDA approves Opdivo/Yervoy combo treatment for kidney cancer

    News

    FDA grants fast track designation to Proteostasis CF therapy

    News

    Sanofi seeks EMA approval for asthma drug Dupixent

  • Clinical Research

    Clinical Research

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    TaiwanJ’s JKB-121 falls victim to unexpected placebo response in NASH patients

    Comment

    ILC 2018: NGM’s intravenous NASH therapy shows rapid reduction in liver fat content and fibrosis

    News

    Potential drug target for anti-obesity treatment discovered

  • Clinical Trials

    Clinical Trials

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    TaiwanJ’s JKB-121 falls victim to unexpected placebo response in NASH patients

    Comment

    ILC 2018: NGM’s intravenous NASH therapy shows rapid reduction in liver fat content and fibrosis

    News

    Merck to begin two Phase III trials of PCV-15 (V114)

  • Diseases

    Diseases

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    TaiwanJ’s JKB-121 falls victim to unexpected placebo response in NASH patients

    Comment

    ILC 2018: NGM’s intravenous NASH therapy shows rapid reduction in liver fat content and fibrosis

    News

    Potential drug target for anti-obesity treatment discovered

  • Genomics & Proteomics

    Genomics & Proteomics

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    Lack of CMO availability threatens cell and gene therapy development

    Comment

    The age of immortality

    Comment

    CD47-targeted therapies: the breast cancer mop?

  • Market Data

    Market Data

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    Comment

    CD40 agonist developments could support Anti-PD-(L)1 therapy in pancreatic cancer

    Comment

    ILC 2018: Madrigal Therapeutics’ MCL-3196 reduces liver fat in NASH patients

    Comment

    ILC 2018: Allergan’s cenicriviroc shows continued fibrosis response in NASH patients in two year extended study

  • Technology

    Technology

      • Projects
      • Analysis
      • News
      • Suppliers
      • White Papers
      • Videos
      • Comment
    News

    Algorithm optimises peptides to target drug-resistant bacteria

    News

    Computer simulation offers digital penicillin production

    News

    Synthetic circuits and feedback loops enable bacteria to produce drugs

  • All

    All sections

    • Home
    • News
    • Advertise With Us
    • Company A-Z
    • Analysis
    • About Us
    • Products & Services
    • Comment
    • About Pharma Technology Focus Magazine
    • Company Releases
    • Projects
    • About Us Online
    • White Papers
    • Events
    • Contact Us
    • Videos
  • Trending:

    • Clinical Trials
    • Technology

    About Us

    Online

    Read more

    In Print

    Read more

    GlobalData Report Store

    Get important industry news and analysis sent to your inbox.

    • About Us
    • Contact Us
    • Company A-Z
    • Privacy Policy
    • Terms and Conditions

    © Copyright 2018 Kable, a trading division of Kable Intelligence Limited.

    Go Top

    • Lost Password Back ⟶
    • Login
    • Register
    Lost Password?
    Registration is disabled.